BC Cancer - Victoria

2410 Lee Avenue
Victoria, BC, V8R 6V5

Clinical Trial Unit Manager
Philip Pollock
250-519-5597
philip.pollock@bccancer.bc.ca

Head and neck

INTERLINK-1: A Phase 3 Randomized, Double-blind, Multicenter, Global Study of Monalizumab or Placebo in Combination With Cetuximab in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Previously Treated With an Immune Checkpoint Inhibitor

Cancer Type
Head and neck
Phase III
Recruiting Dates
BC Cancer - Victoria
Open Recruiting Date
View on ClinicalTrials.gov
Back to top